Study Startup Solutions

Build Revenue

Effective management of your clinical trials startup process can significantly and positively affect your bottom line.

Services include Startup Project Management, Site Feasibility, Site Regulatory Document Collection, Local and Central IRB Management services, CDA and CTA agreements process management and negotiation.

Clinical Trial Startup Services to the pharmaceutical, biotechnology and medical device industries.

Study Startup Solutions focused expertise enables us to provide accelerated, study-startup services to get your sites up and running faster thereby reducing study timelines and cost.

The Study Startup Phase is a time-consuming component of the clinical study process. Delays in completing the study startup phase lead to delays in submission, approval, and product launch—ultimately resulting in potential lost revenues of millions of dollars. Study Startup Solutions’ expedited and effective management of your clinical trials startup process can significantly and positively affect your bottom line.

Study Startup Solutions utilizes streamlined and proprietary processes creating efficiencies at every step in the startup phase and resulting in shortened lead times for your trials regardless of the size of the trial.

Study Startup Solutions� boutique size and highly focused service offerings allow us to be nimble in working with both large and small BioPharma companies to provide both entity and trial tailored services. Additionally, regardless of the size of your organization or trial, our focus provides management efficiencies in allowing your internal project managers to focus on the key components of the trial itself rather than focusing on the time intensive site and document management requirements of the startup phase. Fiscal efficiencies are also realized as Study Startup Solutions provides essential services at reasonable fees during high intensity periods thus reducing the need for your R&D department to maintain staff during slower periods of the trial.